Evidence supporting the use of: Vitamin E (tocotrienol unspecified)
For the health condition: Dementia

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E, including both tocopherols and tocotrienols (though most studies focus on alpha-tocopherol), has been investigated for its potential role in supporting or treating dementia, particularly Alzheimer's disease. The rationale stems from vitamin E's antioxidant properties, which could theoretically help counteract oxidative stress observed in neurodegenerative diseases. Some clinical studies have explored whether vitamin E supplementation slows the progression of dementia. For example, a notable randomized controlled trial published in the New England Journal of Medicine (Sano et al., 1997) found that high-dose vitamin E modestly delayed functional decline in patients with moderately severe Alzheimer's disease. However, results across studies are mixed—other large trials (e.g., the Alzheimer's Disease Cooperative Study) have produced inconclusive or negative results, and some meta-analyses have highlighted potential safety concerns with high-dose supplementation.

Regarding tocotrienols specifically, evidence is limited and much less robust than for tocopherols. Most research on tocotrienols is preclinical, and few direct clinical studies address their role in dementia. Overall, while there is some scientific basis for exploring vitamin E as a supportive therapy in dementia, the evidence is not strong or consistent, and its clinical use is not universally recommended. The rating of 2 reflects the presence of some clinical research, though not enough to support widespread or routine use, especially when considering the specific case of tocotrienols.

More about Vitamin E (tocotrienol unspecified)
More about Dementia

Products containing Vitamin E (tocotrienol unspecified)

We currently have no products on Vitabase that contain this ingredient.